Bluebird Bio (BLUE) Gets a Buy from Barclays
In a report released on March 28, Gena Wang from Barclays maintained a Buy rating on Bluebird Bio (BLUE – Research Report), with a price target ...
Business Insider1mon
Barclays Remains a Buy on Blue Owl Capital (OWL)
In a report released today, Benjamin Budish from Barclays maintained a Buy rating on Blue Owl Capital (OWL – Research Report), with a price target of $29.00. The company’s shares closed ...
Hosted on MSN1mon
Barclays Initiates Coverage of Blue Owl Capital (OWL) with Overweight Recommendation
Fintel reports that on February 24, 2025, Barclays initiated coverage of Blue Owl Capital (NYSE:OWL) with a Overweight recommendation. Analyst Price Forecast Suggests 26.75% Upside As of February ...
ETF Daily News1mon
Barclays Begins Coverage on Blue Owl Capital (NYSE:OWL)
Blue Owl Capital stock opened at $21.79 on Monday. The firm’s fifty day moving average price is $23.95 and its 200 day moving average price is $21.88. The company has a market capitalization of ...